Avivagen (TSXV:VIV) EPS (Basic) : C$-0.06 (TTM As of Jul. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Avivagen EPS (Basic)?

Avivagen's basic earnings per share (Basic EPS) for the three months ended in Jul. 2023 was C$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jul. 2023 was C$-0.06.

Avivagen's EPS (Diluted) for the three months ended in Jul. 2023 was C$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jul. 2023 was C$-0.06.

Avivagen's EPS without NRI for the three months ended in Jul. 2023 was C$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jul. 2023 was -0.04.

During the past 3 years, the average EPS without NRI Growth Rate was 34.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 24.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Avivagen's highest 3-Year average EPS without NRI Growth Rate was 40.30% per year. The lowest was -16.90% per year. And the median was 11.80% per year.

Avivagen EPS (Basic) Historical Data

The historical data trend for Avivagen's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen EPS (Basic) Chart

Avivagen Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

EPS (Basic)

Get a 7-Day Free Trial

-0.15

-0.14

-0.12

-0.09

Avivagen Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
EPS (Basic)	Get a 7-Day Free Trial															-0.03	-0.02	-0.01	-0.02	-0.01

Avivagen EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Avivagen's Basic EPS for the fiscal year that ended in Oct. 2022 is calculated as

Basic EPS (A: Oct. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.066	-	0)	/	66.028
	=	-0.09

Avivagen's Basic EPS for the quarter that ended in Jul. 2023 is calculated as

Basic EPS (Q: Jul. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.933	-	0)	/	77.695
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06

Avivagen (TSXV:VIV) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Avivagen EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Avivagen's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Avivagen (TSXV:VIV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

VIVXF:USA

Address

100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6

Website

https://www.avivagen.com

Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.